Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2026-02-18 @ 11:16 AM
Study NCT ID:
NCT02279095
Status:
COMPLETED
Last Update Posted:
2025-02-19
First Post:
2014-10-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
Sponsor:
Clementia Pharmaceuticals Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PVO-1A-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None